受强制性开放获取政策约束的文章 - Kei Sato了解详情
无法在其他位置公开访问的文章:2 篇
Characterization of the immune resistance of severe acute respiratory syndrome coronavirus 2 Mu variant and the robust immunity induced by Mu infection
K Uriu, P Cárdenas, E Muñoz, V Barragan, Y Kosugi, K Shirakawa, ...
The Journal of Infectious Diseases 226 (7), 1200-1203, 2022
强制性开放获取政策: US National Institutes of Health, Japan Science and Technology Agency
Inherited chromosomally integrated HHV-6 possibly modulates human gene expression
R Kumata, J Ito, K Sato
Virus Genes 56 (3), 386-389, 2020
强制性开放获取政策: US National Institutes of Health
可在其他位置公开访问的文章:89 篇
SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion
P Mlcochova, SA Kemp, MS Dhar, G Papa, B Meng, IATM Ferreira, R Datir, ...
Nature 599 (7883), 114-119, 2021
强制性开放获取政策: Bill & Melinda Gates Foundation, Department of Biotechnology, India, UK …
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
B Meng, A Abdullahi, IATM Ferreira, N Goonawardane, A Saito, I Kimura, ...
Nature 603 (7902), 706-714, 2022
强制性开放获取政策: Bill & Melinda Gates Foundation, US National Institutes of Health, Howard …
SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant
Y Konno, I Kimura, K Uriu, M Fukushi, T Irie, Y Koyanagi, D Sauter, ...
Cell reports 32 (12), 2020
强制性开放获取政策: Federal Ministry of Education and Research, Germany
Virological characteristics of the SARS-CoV-2 Omicron BA. 2 spike
D Yamasoba, I Kimura, H Nasser, Y Morioka, N Nao, J Ito, K Uriu, ...
Cell 185 (12), 2103-2115. e19, 2022
强制性开放获取政策: Japan Science and Technology Agency
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
T Tamura, J Ito, K Uriu, J Zahradnik, I Kida, Y Anraku, H Nasser, M Shofa, ...
Nature communications 14 (1), 2800, 2023
强制性开放获取政策: German Research Foundation, Federal Ministry of Education and Research …
Virological characteristics of the SARS-CoV-2 Omicron BA. 2 subvariants, including BA. 4 and BA. 5
I Kimura, D Yamasoba, T Tamura, N Nao, T Suzuki, Y Oda, S Mitoma, J Ito, ...
Cell 185 (21), 3992-4007. e16, 2022
强制性开放获取政策: Japan Science and Technology Agency
Neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine serum
K Uriu, I Kimura, K Shirakawa, A Takaori-Kondo, T Nakada, A Kaneda, ...
New England Journal of Medicine 385 (25), 2397-2399, 2021
强制性开放获取政策: Patient-Centered Outcomes Research Institute
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
D Yamasoba, Y Kosugi, I Kimura, S Fujita, K Uriu, J Ito, K Sato
The Lancet Infectious Diseases 22 (7), 942-943, 2022
强制性开放获取政策: Japan Science and Technology Agency
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
C Prelli Bozzo, R Nchioua, M Volcic, L Koepke, J Krüger, D Schütz, ...
Nature communications 12 (1), 4584, 2021
强制性开放获取政策: German Research Foundation, European Commission, Federal Ministry of …
SARS-CoV-2 B. 1.617 mutations L452R and E484Q are not synergistic for antibody evasion
IATM Ferreira, SA Kemp, R Datir, A Saito, B Meng, P Rakshit, ...
The Journal of infectious diseases 224 (6), 989-994, 2021
强制性开放获取政策: Bill & Melinda Gates Foundation, Department of Biotechnology, India, UK …
SARS-CoV-2 B. 1.617. 2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough
P Mlcochova, S Kemp, MS Dhar, G Papa, B Meng, S Mishra, C Whittaker, ...
强制性开放获取政策: Bill & Melinda Gates Foundation, Department of Biotechnology, India, UK …
Virological characteristics of the SARS-CoV-2 Omicron BA. 2.75 variant
A Saito, T Tamura, J Zahradnik, S Deguchi, K Tabata, Y Anraku, I Kimura, ...
Cell host & microbe 30 (11), 1540-1555. e15, 2022
强制性开放获取政策: Japan Science and Technology Agency
Virological characteristics of the SARS-CoV-2 omicron XBB. 1.16 variant
D Yamasoba, K Uriu, A Plianchaisuk, Y Kosugi, L Pan, J Zahradnik, J Ito, ...
The Lancet Infectious Diseases 23 (6), 655-656, 2023
强制性开放获取政策: Japan Science and Technology Agency
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB. 1.5 variant
K Uriu, J Ito, J Zahradnik, S Fujita, Y Kosugi, G Schreiber, K Sato
The Lancet infectious diseases 23 (3), 280-281, 2023
强制性开放获取政策: Japan Science and Technology Agency
Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA. 2.86 variant
K Uriu, J Ito, Y Kosugi, YL Tanaka, Y Mugita, Z Guo, AA Hinay, O Putri, ...
The Lancet Infectious Diseases 23 (11), e460-e461, 2023
强制性开放获取政策: Japan Science and Technology Agency
SARS-CoV-2 Omicron spike mediated immune escape and tropism shift
B Meng, IATM Ferreira, A Abdullahi, N Goonawardane, A Saito, I Kimura, ...
BioRxiv, 2021.12. 17.473248, 2021
强制性开放获取政策: Bill & Melinda Gates Foundation, US National Institutes of Health, Howard …
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ. 1.1 variant
J Ito, R Suzuki, K Uriu, Y Itakura, J Zahradnik, KT Kimura, S Deguchi, ...
Nature communications 14 (1), 2671, 2023
强制性开放获取政策: UK Medical Research Council, Japan Science and Technology Agency
Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells
YS Hwang, S Suzuki, Y Seita, J Ito, Y Sakata, H Aso, K Sato, BP Hermann, ...
Nature Communications 11 (1), 5656, 2020
强制性开放获取政策: US National Institutes of Health
出版信息和资助信息由计算机程序自动确定